#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia A with anti factor VIII Immunodeficiency common variable HER2 mutant non-small cell lung cancer Dementia with Lewy bodies Lymphangioma Primary hyperoxaluria Thrombotic thrombocytopenic purpura Juvenile psoriatic arthritis Ventricular tachycardia Spinal cord injury cervical Anti-neutrophil cytoplasmic antibody positive vasculitis Chondrodystrophy Immune-mediated myositis Aicardi-Goutieres syndrome Neonatal alloimmune thrombocytopenia More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma refractory – Basic Information Fabry’s disease – Diagnostics Osteosarcoma recurrent – Trials in Disease Encephalitis autoimmune – Treatment Angiosarcoma non-metastatic – Treatment Hereditary optic atrophy – Basic Information Pulmonary fibrosis – Treatment IgA nephropathy Phenylketonuria – Diagnostics Angiosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Florbetapir (18F) Triamcinolone Acetonide Domperidone Ly3871801 HUMAN THROMBIN L-PHENYLALANINE Dalbavancin Idursulfase Mva-209-Fsp-B1 Tyra-300-B01 Larotrectinib Sulfate Batoprotafib Deferiprone PROMESTRIENE Mycophenolic Acid Formoterol Fumarate Diphenhydramine Amikacin Minocycline Annamycin More therapies…

    Learn about Your Condition

    Prinzmetal angina Ischaemic stroke Radicular pain Bartonellosis Hepatoblastoma Synovial sarcoma Ventricular tachycardia Peritoneal neoplasm Acute kidney injury Proteinuria Cerebrovascular accident Short-bowel syndrome Thyroidectomy Bipolar disorder Paresis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Safety and Effects of YTB323 and Drug Combination in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    • Primary progressive multiple sclerosis
    Investigated Drugs:
    • Cyclophosphamide
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    France Germany Italy Spain

  • Study on Melatonin and Quetiapine for Treating Insomnia in Adolescents with Psychiatric Disorders

    Recruiting

    4 1 1
    Investigated Diseases:
    • Attention deficit hyperactivity disorder
    • Schizoaffective disorder
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark

  • Study on Adding Vasopressin to Treat Patients with Septic Shock

    Recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Argipressin
    • Sodium Chloride
    France

  • Study on Rituximab for Patients with Rheumatoid Arthritis: Comparing 200 mg and 1g Doses for Maintenance Treatment

    Recruiting

    3 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    • Rituximab
    France

  • Long-term Safety and Efficacy Study of Etuvetidigene Autotemcel for Patients with Wiskott-Aldrich Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Wiskott-Aldrich syndrome
    Investigated Drugs:
    • Etuvetidigene Autotemcel
    Italy

  • Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • ALE.P02
    • Pembrolizumab
    France Italy Spain
Previous Page
1 … 230 231 232 233 234 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!